Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.
about
Aspirin as adjunctive treatment for giant cell arteritisNeuro-Ophthalmological EmergenciesPolymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.The treatment of giant cell arteritisAutoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly.Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohortRisk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.Large-vessel vasculitis.Clinical course and management of a consecutive series of patients with "healed temporal arteritis".Risk factors for early visual deterioration in temporal arteritis.The emergency room in systemic rheumatic diseases.Morphological features of temporal arteritis.A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA): Clinical Features and Factors Associated With Severe Ischemic ManifestationsUpdate on the use of biologics in primary systemic vasculitides.Delays in recognition and management of giant cell arteritis: results from a retrospective audit.Clinical diagnosis and management of large vessel vasculitis: giant cell arteritis.The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.Antithrombotic therapy in aortic diseases: A narrative review.Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.Visual loss and other cranial ischaemic complications in giant cell arteritis.Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell ArteritisGiant cell arteritis presenting as critical lower limb ischemia.Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases.Anterior uveitis as an initial manifestation of polymyalgia rheumatica.Giant cell arteritis in a 12-year-old girl presenting with nephrotic syndrome.Heparin therapy in giant cell arteritis.Bilateral scalp necrosis with giant cell arteritis.Recovery of vision after bilateral arteritic central retinal artery occlusion.The Utility of Color Duplex Ultrasonography in the Diagnosis of Giant Cell Arteritis: A Prospective, Masked Study. (An American Ophthalmological Society Thesis).
P2860
Q24194497-3ABEB5DE-A09C-445A-B1F9-7FB9D67826F2Q26783463-B0C148D3-51E7-480C-84BE-B14DCD2E9C25Q34205665-2D383FC5-885B-47A4-B382-B2D93F47B7E4Q34461224-48CF5394-2360-498B-AEEA-475C176974B3Q35135284-E9073713-FAC0-466E-863A-084909707324Q35200098-22411ACB-DD29-4C82-BC8B-1EB05DF612EAQ35237977-882F9C39-1119-43D9-A0E2-A85CBA16F433Q35661553-6F4C8693-0355-4471-AAD5-3065CF166C52Q35729917-4C2D3882-18CF-4C3C-8AE0-E1788DE2C92CQ36226768-FA35166B-B6D5-4C4C-B5E3-F9AC4ABD3D04Q36571929-345AED66-2210-4106-B551-2656C630BFBDQ36703104-D449A33B-8915-46BC-AD30-4A21948D39B6Q37205901-6E23E47A-F4CF-47EC-8A18-CECB74A84865Q37754811-BD3149D7-0FA4-42A0-92E5-639DC22D3FCCQ37810491-463B8EC7-E23C-4649-B236-AFA666D8D10DQ38217341-E7C03360-7065-4D45-AD72-528937CCD453Q39121484-45D7EFBC-8FAE-4354-B219-A976D44D5AA5Q39142382-6D59732B-5CD7-4291-9A1D-126FBB933565Q39331967-D460763F-DC68-49EA-AF62-C68703757E97Q39416333-0D51E4E5-5B12-4F8B-A2F1-8A79DE93BF5FQ39686214-BCFBE33E-AAC8-4D77-B013-982D16428A05Q40135144-F5A7A4C2-3EAB-4C8B-A1A5-50D17A2705CEQ41156625-093F0620-2524-4054-90D8-AD7C76E2BB57Q41787560-4674F823-EB94-46C5-B776-3CB771A98A61Q41851579-7E6DF97E-83BF-4A56-883E-83F44D06333DQ43008075-7D7A04FB-89A9-4517-98A5-CAC3BE7705E1Q44401370-D1EF9006-4B7B-43F0-B0E5-CBA93FA26095Q44833285-39A59B67-FB79-4818-85D1-7AAA103F881BQ55439546-8AA27708-FAA9-4668-85BA-4125459B4A90
P2860
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Risk factors for visual loss i ...... pective study of 174 patients.
@en
Risk factors for visual loss in giant cell
@nl
type
label
Risk factors for visual loss i ...... pective study of 174 patients.
@en
Risk factors for visual loss in giant cell
@nl
prefLabel
Risk factors for visual loss i ...... pective study of 174 patients.
@en
Risk factors for visual loss in giant cell
@nl
P2093
P1476
Risk factors for visual loss i ...... pective study of 174 patients.
@en
P2093
P304
P356
10.1016/S0002-9343(01)00770-7
P407
P577
2001-08-01T00:00:00Z